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Because of dogs' unique population structure, human-like disease biology, and advantageous genomic features, the
canine system has risen dramatically in popularity as a tool for discovering disease alleles that have been difficult to find
by studying human families or populations. To date, disease studies in dogs have primarily employed either linkage
analysis, leveraging the typically large family size, or genome-wide association, which requires only modest-sized case and
control groups in dogs. Both have been successful but, like most techniques, each requires a specific combination of time
and money, and there are inherent problems associated with each. Here we review the first report of mRNA-Seq in the
dog, a study that provides insights into the potential value of applying high-throughput sequencing to the study of
genetic diseases in dogs.
Forman and colleagues apply high-throughput sequencing to a single case of canine neonatal cerebellar cortical
degeneration. This implementation of whole genome mRNA sequencing, the first reported in dog, is additionally unusual
due to the analysis: the data was used not to examine transcript levels or annotate genes, but as a form of target capture
that revealed the sequence of transcripts of genes associated with ataxia in humans. This approach entails risks. It would
fail if, for example, the relevant transcripts were not sufficiently expressed for genotyping or were not associated with
ataxia in humans. But here it pays off handsomely, identifying a single frameshift mutation that segregates with the
disease. This work sets the stage for similar studies that take advantage of recent advances in genomics while exploiting
the historical background of dog breeds to identify disease-causing mutations.
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The domestic dog offers unique advantages to the study
of complex and multilocus diseases. Breeds are closed
populations; membership requires that all parents and
grandparents be registered members of the same breed.
The division of the population into over 350 breeds sim-
plifies the locus heterogeneity that is typically associated
with complex diseases [1,2]. Finally, many breeds share
recent common ancestors [3-5], meaning that they also
likely share common disease alleles, offering an avenue
to increase power and resolution for genetic studies.
The genome of the dog was sequenced to 7.5x in 2005
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distribution, and reproduction in any mediumwithin-breed linkage disequilibrium (LD) [6,7] and the
high degree of across-breed heterogeneity. As a result,
genome wide association studies (GWAS) require chips
with no more the 100,000 single nucleotide polymorph-
isms (SNPs) (see [8] for review). Finally, the relatedness of
breeds means that transitioning from marker to mutation
can often be accomplished by combining data from
affected individuals from related breeds [9,10].
Nevertheless, the dog system has some disadvantages.
For instance, while dog families may be very large, thus
allowing disease genes to be found by linkage analysis of a
single large family [11], locating and sampling all the ne-
cessary dogs can be problematic. Second, while GWAS
have been successful at identifying many loci of interest
[12], the extensive LD means that getting from associated
locus to mutation can be difficult [8,13].Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
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genome-wide mRNA sequencing (RNA-Seq) to find the
variant associated with a form of neonatal cerebellar cor-
tical degeneration, circumvents many of these problems.
By way of background, the disorder is a neurodegenera-
tive disease occurring in several breeds, including the
beagle. Affected dogs suffer from a loss of balance, unco-
ordinated gate, and an inability to regulate movement.
Loss of Purkinje cells with swollen dendritic processes is
the pathologic hallmark of this recessive disorder [15].
The authors performed genome wide mRNA sequen-
cing using cerebellum tissue from one affected pup. Im-
portantly, they focused their resulting search exclusively
on the 27 dog genes that were known orthologs of human
ataxia genes. In this sense they got lucky—there are 41
such human loci and causal genes identified for only 28.
Of those, dog orthologs are known for 27. Had the causa-
tive gene not been previously identified as an ataxia gene
in human studies, the cause of the canine disease would
not have been found using this approach. After compari-
son to common dog SNPs and orthologous sequences,
variants were eliminated if they were non-coding, hetero-
zygous or conserved. The remaining variant, located in
the β-III spectrin gene (SPTB2), was an eight base pair
(bp) coding deletion that is predicted to cause both an ab-
errant run of 27 extra amino acids and premature termin-
ation of mRNA. The mutation segregated perfectly as an
autosomal recessive in the small family tested, was found
in the heterozygous state in other unaffected but at-risk
dogs, and was absent in 37 other breeds. As expected,
cerebellum tissue from the proband, showed a near total
loss of both β-III spectrin mRNA and protein when com-
pared to an unspecified control.
β-III spectrin is a superb candidate gene. The gene fam-
ily encodes cytoskeletal proteins that are important struc-
tural components of the plasma membrane. β-III spectrin
is found in the nervous system, with the highest levels of
expression in the Purkinje cell soma and dendrites [16].
There is, thus, no doubt the correct gene has been found.
While the authors are to be commended for synthesizing
a wide range of knowledge and tools to construct a strong
argument for their findings, the generalizability of the ap-
proach has to be questioned. The authors point out, cor-
rectly, that because mRNA-seq requires far fewer samples
than does a GWAS, less time is needed to collect samples
and complete projects. In this case, however, the authors
were well-informed regarding the correct tissue to se-
quence and candidate genes to consider. That will not al-
ways be the case. Also, this approach is likely to miss
weakly expressed transcripts, which could be important for
some diseases. While not simple, a library normalization
step could certainly be incorporated. A major argument for
sequencing and pursuing genetic studies in the dog is the
simplified genetic architecture: reduced locus heterogeneityimproves the chances for identifying variants underlying
complex disease traits and a shared genetic background
makes disease presentation more uniform. Focusing solely
on known human disease genes dismisses both of these
advantages.
Does this lessen the impact of the paper? In light of
the rapid advances in human genetics, particular with
regard to rare genetic diseases, we would argue no.
There are many cases where families of human genes
are known, but their precise matchup with clinical fea-
tures remains ambiguous. This practice of using candi-
date gene/mRNA sequencing will resolve many such
cases. The argument for greater clarity in phenotype be-
cause of the similar genetic background of breed mem-
bers can still apply, albeit in a different way. Finally,
animal models that result from studies such of that of
Forman [14] are clinically valuable.
The number of human genes associate with both com-
mon and rare diseases is increasing at an amazing rate.
These authors offer a way to take advantage of such
advances while making use of the extraordinary advan-
tages of the canine system, resulting in gene discovery
that is applicable to both human and companion animal
health.
Conclusions
Applying mRNAseq methods from carefully selected tis-
sues to pre-selected candidate genes, while not a substi-
tute for the GWAS or linkage studies, can reveal causative
mutations for multilocus diseases.
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